These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1903236

  • 1. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.
    Cusimano G, Capriani C, Bonifati V, Meco G.
    Acta Neurol Scand; 1991 Mar; 83(3):145-50. PubMed ID: 1903236
    [Abstract] [Full Text] [Related]

  • 2. Function of dopamine receptors in young-onset Parkinson's disease: prolactin response.
    Kostic VS, Marinkovic Z, Filipovic S, Momcilovic D.
    Mov Disord; 1993 Apr; 8(2):227-9. PubMed ID: 8474497
    [Abstract] [Full Text] [Related]

  • 3. [Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
    Díaz F, Liberman C, Chariá P.
    Rev Med Chil; 1991 Mar; 119(3):252-7. PubMed ID: 1842116
    [Abstract] [Full Text] [Related]

  • 4. Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.
    Vogel HP, Ketsche R.
    J Neurol; 1986 Jun; 233(3):149-52. PubMed ID: 3088217
    [Abstract] [Full Text] [Related]

  • 5. Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response.
    Agnoli A, Baldassarre M, Ruggieri S, Falaschi P, Urso RD, Rocco A.
    J Neural Transm; 1981 Jun; 51(1-2):123-34. PubMed ID: 7264625
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
    Sakuma H, Takase S, Mizuno Y, Teramura K, Hanew K.
    Tohoku J Exp Med; 1988 Nov; 156(3):291-8. PubMed ID: 3252557
    [Abstract] [Full Text] [Related]

  • 7. Tuberoinfundibular dopaminergic system and anterior pituitary dopamine receptor in Shy-Drager syndrome.
    Konagaya Y, Konagaya M, Takayanagi T.
    J Neurol Sci; 1985 Jan; 67(1):93-103. PubMed ID: 3981215
    [Abstract] [Full Text] [Related]

  • 8. Provocative hypothalamopituitary axis tests in severe head injury: correlations with severity and prognosis.
    Della Corte F, Mancini A, Valle D, Gallizzi F, Carducci P, Mignani V, De Marinis L.
    Crit Care Med; 1998 Aug; 26(8):1419-26. PubMed ID: 9710103
    [Abstract] [Full Text] [Related]

  • 9. Prolactin and thyrotrophin responses to thyroliberin (TRH) in patients with growth hormone deficiency: study in 167 patients.
    Garnier PE, Roger M, Chaussain JL, Canlorbe P, Job JC.
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):433-40. PubMed ID: 6412497
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.
    Lestingi L, Bonifati V, Stocchi F, Antonozzi I, Meco G.
    Eur Neurol; 1992 Aug; 32(2):65-9. PubMed ID: 1563463
    [Abstract] [Full Text] [Related]

  • 12. Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease.
    Martinez-Campos A, Giovannini P, Novelli A, Cocchi D, Caraceni T, Müller EE.
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):344-51. PubMed ID: 6803485
    [Abstract] [Full Text] [Related]

  • 13. Endocrine aspects of bromocriptine therapy in Parkinsonism.
    Shaw KM, Lees AJ, Franks S, Daggett P, Thompson BD, Stern GM.
    J Neural Transm; 1978 Mar; 43(2):153-60. PubMed ID: 104006
    [Abstract] [Full Text] [Related]

  • 14. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 15. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E, Ranta T, Seppäla M.
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [Abstract] [Full Text] [Related]

  • 16. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT, Hershman JM, Boyd AE, Longcope C, Bacharach P.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [Abstract] [Full Text] [Related]

  • 17. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL, Pepperell RJ, Stockdale J, Bremner WJ, Burger HG.
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [Abstract] [Full Text] [Related]

  • 18. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.
    Eskildsen PC, Kirkegaard CB.
    J Endocrinol Invest; 1985 Oct; 8(5):427-31. PubMed ID: 3935709
    [Abstract] [Full Text] [Related]

  • 19. The prolactin-releasing mechanism of the hypothalamo-pituitary axis in pregnancy.
    Kubota T, Yaoi Y, Nagae M, Kumasaka T, Saito M.
    Fertil Steril; 1984 Nov; 42(5):724-9. PubMed ID: 6436068
    [Abstract] [Full Text] [Related]

  • 20. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L, Reschini E, Catania A, Giustina G.
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.